Search

FDA (Silver Spring, Maryland) is offering a postbac fellowship to develop and characterize phage therapy for decolonizing Vancomycin-resistant Enterococci, focusing on overcoming bacterial resistance.

The University of Pennsylvania is hiring a Research Specialist to lead a project on molecular interactions between bacteria and phage.

FAPESP, São Paulo, Brazil is hiring a postdoc to explore the applications of bactericidal type IV secretion systems, focusing on interspecies bacterial warfare and the development of new tools for targeting pathogens.

Washington University (St. Louis, USA) is hiring a Research Technician II to support phage and bacterial host interaction studies, involving molecular biology, cell biology, and genomics.

This week on PhageCast, the team talked to Paul Turner about how his lab is predicting the trade-offs of bacterial resistance to phage, to achieve killing by reversing the antibiotic resistance. They also covered how these findings are tran

The International Society of Microbiota will host their 11th Annual Meeting, Targeting Microbiota, on October 17-18 at the Corinthia Palace Malta, to explore the role of microbiota in health and disease, advancements in microbiome medicine,

Pherecydes has a new phage therapy patent. It covers new S. aureus phages and their manufacture and combination for use in phage therapy and as a companion diagnostic.

NIAID seeks applications from single institutions or consortia ready to generate, validate, and advance medical countermeasures against drug-resistant bacteria or fungi.

Nicholas Smith (University at Buffalo) and colleagues published a new paper exploring the pharmacodynamics of three unique Pseudomonas phages by simulating different dosing strategies (cocktails vs. single phage, bolus vs. prolonged dosing)

Ana Rita Costa (Delft University of Technology) and colleagues published a new paper showing that clinical P. aeruginosa strains accumulate phage defense systems (some have at least 19!), that many individual defense systems target specific

Ritu Arora (University of Delhi) and colleagues isolated 100+ mycobacteriophages over the last two years, and here announce five genomes from different clusters, infecting M. tuberculosis and M. fortuitum.

We’re excited to embark on another new chapter this year, this time in the San Francisco Bay Area! Here’s some reflections on the transition now that we’re stateside, what we’re thinking about these days, and a sneak peek into what’s in sto

Returning to Boston next week (February 27-29), the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Check the agenda & get your ticket ASAP! Join 18+ expert speakers from Merck, Pfize

PhageCast recently interviewed Lorenzo Corsini about why Staph phages don’t work well in plasma or synovial fluid, and talked to Jean-Paul Pirnay (2-part series) about the Queen Astrid Military Hospital’s first 100 documented cases of phage

Greg German (Unity Health Toronto) has been awarded a Professorship at the University of Toronto for Bacteriophage Research and Innovation with a five year term. Congrats Greg!

In an article featured in BioSpectrum India, Atif Khan, a scientist at the Biofouling and Biofilm Processes Section of the Bhabha Atomic Research Centre, India discusses the likely establishment of phage infrastructure in India within the n

Michael Shamash, a gut phageome PhD student at McGill University, explores the influence of gut phages on the human microbiome and their potential impact on health in a podcast interview with Justine Dees at the Joyful Microbe.

Hugo Oliveira (University of Minho) will share insights from in vitro and in vivo studies on a phage-derived protein on February 29th at 11 AM GMT as part of the Africa Phage Forum series. Register here.

Only 4 months remain until the Viruses of Microbes 2024 Meeting takes place (July 15-19, 2024). Phage researchers are encouraged to confirm their participation early to plan for the trip down under!

From David Bikard via Twitter: A question to the phage aficionado. Do you have clear examples of anti-phage defense systems that block the production or assembly of phage particles without targeting the phage DNA and without resulting in ce